Results showed that STC-1 expression in PB and/or BM, apart from lymph metastasis and advanced stage, were independent factors for predicting an adverse 2-year PFS for ESCC patients (Table 5). This evidence concerns the gene STC1 and esophageal squamous cell carcinoma.